Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

Clinical Study of Extra-anatomic Bypass

해부외 회로 조성술에 관한 임상적 고찰

  • Kim Jong Won (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Pusan National University) ;
  • Chung Sung Woon (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Pusan National University)
  • 김종원 (부산대학교 의과대학 흉부외과학교실) ;
  • 정성운 (부산대학교 의과대학 흉부외과학교실)
  • Published : 2005.05.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Extra-anatomic bypass was performed in the patient who could not use anatomic bypass due to many causes. The purpose of this study is to evaluate the efficacy of extra-anatomic bypass surgery. Material and Method: We reviewed 31 patients who underwent extra-anatomic bypass surgery at Pusan national university hospital. We analysed the combined diseases, etiologic diseases, symptoms, patency rate and the factors affecting patency rate retrospectively. Result: There were 26 cases of femoro-femoral bypass and 5 cases of axillo-bifemoral bypass among 31 patients. The mean age was 70.23 years. Combined disease were hypertension, hyperlipidemia, and ischemic heart disease in order of frequency. The indications for surgery were disabled claudication, tissue necrosis, rest pain, and a cute ischemia. We analysed the ages, smoking history, hypertension, ischemic heart disease, severity of limb ischemia, and hyperlipidemia as factors affecting patency rate. We could not find any statistical differences between these factors. The primary graft patency rates were $73.65\%$ one year, $73.65\%$ two year, and $65.46\%$ three year respectively according to the Kaplan-Meier method. Conclusion: Nevertheless extra-anatomic bypass has a relatively low patency rate, it has good merits that is less dangerous, simple and easy re-do surgery compared to anatomic bypass. We think that extra-anatomic bypass is one of the good treatment modalities for the high risk vascular patients.

해부학적 회로 조성술을 이용할 수 없는 환자에게서 시행되는 해부외 회로 조성술에 대하여 이술식의 적정성을 알아보고자 본 연구를 시행하였다. 대상 및 방법: 부산대학교병원 흉부외과에서 해부외 회로 조성술을 시행받은 31명의 환자를 대상으로 동반질환, 원인질환, 수술 당시의 증상, 개존율과 개존율에 영향을 미치는 요인 등을 분석하였다. 결과: 31예의 수술 중 대퇴-대퇴동맥 우회술이 26예, 액와-대퇴동맥 우회술이 5예였고 평균 연령은 70.23세였다. 동반질환은 고혈압, 고지혈증, 허혈성심질환의 순이었고 수술 적응증은 파행, 조직괴사, 휴식기 통증 등의 순이었다. 대퇴-대퇴동맥 우회술을 대상으로 이식편의 일차 개존율에 영향을 미치는 요인들을 분석하였으나 나이(65세 이상), 흡연력, 고혈압, 허혈성 심장질환, 심한 하지 허혈, 고지혈증 등의 유무에 따른 개존율은 통계학적으로 유의한 차이가 없었다. Kaplan-Meier법을 이용한 이식편의 일차 개존율은 1년 $73.65\%$, 2년 $73.65\%$, 3년$65.46\%$였다. 결론: 수술의 위험도가 높은 환자들에게서 해부외 회로 조성술은 해부학적 회로 조성술에 비해서 개존율이 낮다고 알려져 있지만 술식이 간단하고 덜 위험하며 이식혈관 부전시 교정도 상대적으로 쉽게 할 수 있는 장점을 가진 치료법임을 알 수 있었다.

Keywords

References

  1. Brewster DC. Current controversies in management of aortoiliac occlusive disease. J Vasc Surg 1997;25:365-79 https://doi.org/10.1016/S0741-5214(97)70359-8
  2. Nevelsteen A, Wouters L, Suy R. Aorto-femoral Dacron reconstruction for aortoiliac occlusive disease: A 25 year survey. Eur J Vasc Surg 1991;5:179-86 https://doi.org/10.1016/S0950-821X(05)80685-1
  3. Ricco JB. Unilateral iliac artery occlusive disease: A randomized multicenter trial examining direct revascularization versus crossover bypass. Association Universitaire de Recherche en Chirugie. Ann Vasc Surg 1992;6:209-19 https://doi.org/10.1007/BF02000265
  4. Schneider JR, Besso SR, Walsh DB, Zwolak RM. Cronenwett JL: Femorofemoral versus aortobifemoral bypass: Outcome and hemodynamic results. J Vasc Surg 1994;19:43-55 https://doi.org/10.1016/S0741-5214(94)70119-9
  5. Ehrenfeld WL, Harris JD, Wylie EJ. Vascular 'steal' phenomenon: An experimental study. Am J Surg 1968;116:192-7 https://doi.org/10.1016/0002-9610(68)90492-3
  6. Plecha FR, Plecha FM. Femorofemoral bypass grafts: Ten year experience. J Vasc Surg 1984;1:555-61 https://doi.org/10.1067/mva.1984.avs0010555
  7. Lamerton AJ, Nicolaides AN, Eastcott HHG. The femorofemoral grafts: Hemodynamic improvement and patency rate. Arch Surg 1985;120:1274-8 https://doi.org/10.1001/archsurg.1985.01390350056012
  8. Brewster DC. Direct reconstruction for aortoiliac occlusive disease. In: Rutherford RB. Vascular surgery, 5th ed. Philadelpahia: W.B. Saunders. 2000;943-72
  9. Samson RH, Scher LA, Veith FJ. Combined segment arterial disease. Surgery 1985;97:385-96
  10. Brener GJ, Brief DK, Alpert J, et al. Femorofemoral bypass: A twenty-five year experience. In: Yao JST, Pearce WH. Long-term results in vascular surgery. East Norwalk: Appleton & Lange 1993;385-93
  11. Davis RC, O'hara ET, Mannick JA, Vollman RW, Nabseth DC. Broaden indications for femoro-femoral grafts. Surgery 1972;72:980-4
  12. Dick LS, Brief DK, Alpert T, Brenner BJ, Goldenkranz RJ, Parsonnet V. A 12-year experience with femoro-femoral crossover grafts. Arch Surg 1980;115:1359-65 https://doi.org/10.1001/archsurg.1980.01380110091014
  13. Craido E, Burnham SJ, Tinsley EA, Johnson G Jr, Keagy BA. Femorofemoral bypass graft: Analysis of patency and factors influencing long-term outcome. J Vasc Surg 1993;18:495-504 https://doi.org/10.1067/mva.1993.47896
  14. Blaisdell FW, Hall AD. Axillo-femoral artery bypass for lower extremity ischemia. Surgery 1963;54:563-8
  15. Sauvage LR, Wood SJ. Unilateral axillary bilateral femoral bifurcation graft: A procedure for the poor risk patient with aortoiliac disease. Surgery 1966;60:573-7
  16. Passman MA, Taylor LM Jr, Moneta GL, et al. Comparison of axillofemoral and aortofemoral bypass for aortoiliac occlusive disease. J Vasc Surg 1996;23:263-9 https://doi.org/10.1016/S0741-5214(96)70270-7
  17. Rutherford RB. Extra-anatomic bypass. In: Rutherford RB, Vascular Surgery. 5th ed. Philadelphia: W.B. Saunders. 2000;981-97
  18. Wittens CHA, van Houtte HJKP, van Urk H. European Prospective Randomised Multi-center Axillo-bifemoral Trial. Eur J Vasc Surg 1992;6:115-23 https://doi.org/10.1016/S0950-821X(05)80227-0
  19. LoGerfo FW, Johnston WC, Corson JD, et al. A comparison of the late patency rates of axillobilateral femoral and axillounilateral femoral grafts. Surgery 1977;81:33-40